Catholic Health is now offering outpatient COVID-19 Monoclonal Antibody Therapy at St. Joseph Campus in Cheektowaga. Monoclonal Antibody Therapy is designed to treat patients who have received a positive COVID-19 test within the past 10 days and are at high risk of hospitalization. Dr. Thomas Cumbo, Infectious Disease Specialist, is accepting referrals.
To request a referral to the monoclonal infusion clinic at St. Joseph Campus, please fax a referral for Dr. Cumbo with a Diagnosis of COVID-19 and a copy of the patient’s positive COVID-19 test to 716-891-2187.
Dr. Cumbo will perform a consult with your patient and determine that the patient meets criteria for Monoclonal Infusion. If your patient meets the established criteria for monoclonal infusion therapy, your patient will receive the treatment immediately following consult.
Patients must meet the following criteria to receive Monoclonal Antibody Therapy:
- Have had a positive COVID-19 test in the past 10 days
- Have chronic kidney disease
- Had a body mass index (BMI) over 35
- Have diabetes
- Have immunosuppressive disease
- Are currently receiving immunosuppressive treatment
- Are older than 65 years of age
- Are older than 55 years of age AND have:
- Cardiovascular disease OR
- Hypertension OR
- Chronic obstructive pulmonary disease/other chronic respiratory disease.
Patients cannot receive Monoclonal Antibody Therapy if they have one or more of the following:
- Are hospitalized due to COVID-19
- Require oxygen therapy due to COVID-19
- Require an increase in baseline oxygen flow rate due to COVID-19 in those on chronic oxygen therapy due to underlying non-COVID-19 related comorbidity.
Currently, there are two approved monoclonal therapies for COVID-19: Bamlanivimab + Eteseviman (Lilly) and Casirivimab + imdevimab (Regeneron). Please see the attached Emergency Use Authorization information documents regarding these therapies. If you have any questions, please call the Mount St. Mary’s Infectious Diseases Clinic at 716-298-3000.